In our previous study, we determined that PRDX2 is differentially expressed in CRC tissue compared to adjacent normal tissue; increased expression is associated with poor tumor differentiation and advanced “tumor, node, metastasis” (TNM) stages [4]. The gene discussed is PRDX2; the disease is colorectal carcinoma.